Skip to main content
. 2013 May;57(5):2005–2009. doi: 10.1128/AAC.01779-12

Table 2.

Dose proportionality assessment of GSK1322322 pharmacokinetic parameters

Parameter Adjusted mean slope value (90% CI) for GSK1322322 dose
100–1,500 mg 1,500–4,000 mg All doses
AUC0–24 (μg · h/ml) 1.31 (1.23, 1.40) 0.64 (0.27, 1.01) 1.22 (1.09, 1.35)
AUC0–∞ (μg · h/ml) 1.31 (1.23, 1.39) 0.66 (0.30, 1.02) 1.22 (1.10, 1.35)
AUC0–t (μg · h/ml) 1.32 (1.24, 1.40) 0.66 (0.30, 1.02) 1.23 (1.10, 1.36)
Cmax (μg/ml) 1.23 (1.09, 1.37) 0.16 (−1.29, 1.62) 1.04 (0.87, 1.22)